HOXC4 and ependymoma: The previous research identified HOXC4 was strongly overexpressed in pediatric brain tumors, including ependymoma (Mendrzyk et al., 2006), medulloblastomas, glioblastoma multiforme, and juvenile pilocytic astrocytomas (Chakravadhanula et al., 2014).